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Covalent intermolecular cross-linking provides collagen fi-
brilswith stability. The cross-linking chemistry is tissue-specific
and determined primarily by the state of lysine hydroxylation at
specific sites. A recent study on cyclophilin B (CypB) null mice,
amodel of recessive osteogenesis imperfecta, demonstrated that
lysine hydroxylation at the helical cross-linking site of bone type
I collagen was diminished in these animals (Cabral, W. A.,
Perdivara, I., Weis, M., Terajima, M., Blissett, A. R., Chang, W.,
Perosky, J. E., Makareeva, E. N., Mertz, E. L., Leikin, S., Tomer,
K. B., Kozloff, K.M., Eyre, D. R., Yamauchi, M., andMarini, J. C.
(2014) PLoS Genet. 10, e1004465). However, the extent of
decrease appears to be tissue- and molecular site-specific, the
mechanism of which is unknown. Here we report that although
CypB deficiency resulted in lower lysine hydroxylation in the
helical cross-linking sites, it was increased in the telopeptide
cross-linking sites in tendon type I collagen. This resulted in a
decrease in the lysine aldehyde-derived cross-links but genera-
tion of hydroxylysine aldehyde-derived cross-links. The lat-
ter were absent from the wild type and heterozygous mice.
Glycosylation of hydroxylysine residues was moderately
increased in the CypB null tendon.We found that CypB inter-
acted with all lysyl hydroxylase isoforms (isoforms 1–3) and a
putative lysyl hydroxylase-2 chaperone, 65-kDa FK506-bind-
ing protein. Tendon collagen in CypB null mice showed
severe size and organizational abnormalities. The data indi-
cate that CypB modulates collagen cross-linking by differen-
tially affecting lysine hydroxylation in a site-specific manner,
possibly via its interaction with lysyl hydroxylases and asso-
ciated molecules. This study underscores the critical impor-
tance of collagen post-translational modifications in connec-
tive tissue formation.
Collagens comprise a large family of structurally related
extracellularmatrix proteins (1). Among all of the genetic types
of collagen identified, fibrillar type I collagen is the most abun-
dant, providing tissues and organs with form and stability. It is
a heterotrimeric molecule composed of two 1 chains and one
2 chain forming a long uninterrupted triple helix with short
non-helical domains (telopeptide) at both N and C termini.
One of the functionally important characteristics of collagen is
its unique, sequential post-translational modifications of Lys
residues. The modifications include hydroxylation and mono-
and diglycosylation of hydroxylysine (Hyl),3 and oxidative
deamination of Lys and Hyl in the N- and C-telopeptides fol-
lowed by extensive covalent intermolecular cross-linking (2). It
is now clear that defective Lys modifications of collagen cause
and/or are associated with a broad range of connective tissue
disorders, including Ehlers-Danlos syndrome type VIA (3),
bronchopulmonary dysplasia (4), Kuskokwim syndrome (5),
Bruck syndrome (6, 7), fibrosis (8), disuse osteoporosis (9), and
cancer progression (10, 11). Our recent finding showed that a
switch of collagen cross-link phenotype may regulate tumor
cell invasive and metastatic propensities (12).
Hydroxylation of Lys residues in the nascent pro1(I) and
pro2(I) chains occurs in the rough endoplasmic reticulum
(ER) before the formation of a triple helix procollagen mole-
cule. The reaction is catalyzed by lysyl hydroxylase 1–3
(LH1–3) in the sequence of X-Lys-Gly and X-Lys-Ala/Ser in
the helical and telopeptidyl domains of the procollagen 
chains, respectively (13). Studies indicate that LH1 mainly
functions as a helical LH, and LH2 functions as a telopeptidyl
LH (8, 13–15). LH3, although it possesses both LH and glyco-
syltransferase activities, may mainly function as a galactosylhy-
droxylysyl glucosyltransferase in type I collagen (16–19). These
initial Lys modifications are critical to determine the fate of the
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final modification, covalent intermolecular cross-linking, and
are therefore important for collagen matrix stability. However,
the substrate specificity and the regulatory mechanism of LH
activity are still not well understood.
Recent studies on recessive osteogenesis imperfecta (OI)
have shed light on a controlmechanism suggesting that ER-res-
ident chaperones (i.e. cyclophilin B (CypB) and 65-kDa FK506-
binding protein (FKBP65)) may regulate specific LH activity
directly impacting collagen cross-linking chemistry (20). CypB,
encoded by thePPIB gene, is a peptidyl-prolyl cis-trans-isomer-
ase and a component of the prolyl-3-hydroxylase complex. It is
a multifunctional protein implicated in recessive OI (21–24),
inflammation (25), and cancer (26). Our recent study on
Ppib/ (hereafter referred to as CypB KO)mice (27) provided
evidence that CypB deficiency affects collagen cross-linking by
diminishing Lys hydroxylation specifically at the helical cross-
linking sites in bone type I collagen. Thiswas surprising because
the rate of procollagen chain folding in CypB KO cells was
impaired, and this, according to the traditional view, would
have resulted in Lys overmodification (23). Thus, the decrease
in Lys hydroxylation seen in CypB KO bone is due in part to an
impaired interaction betweenCypB and LH1 that facilitates the
helical LH activity, as proposed by Ishikawa et al. (28). How-
ever, the tissue- andmolecular site-specific effect of CypB defi-
ciency on Lys modifications and its mechanisms are still not
well defined.
To gain further insight into the function of CypB in Lys post-
translational modifications of collagen, fibrillogenesis, and its
potential mechanism, we analyzed type I collagen in CypB KO
mouse tendon, another type I collagen-rich tissue. Here we
report intriguing findings indicating that CypB may differen-
tially regulate Lys modifications at the helical and telopeptidyl
cross-linking sites of collagen, which could be important for the
development and organization of tendon.
Experimental Procedures
Animal care and experiments were performed in accordance
with a protocol approved by the NICHD, National Institutes of
Health, animal care and use committee.
PpibNullMice—Ppib nullmice have recently been generated
as a mouse model of recessive OI (27). In this model, Ppib tran-
scripts andCypB proteinwere not detected in primary cells and
tissues.
Histological Evaluation—Wild type (WT), heterozygous
(Het), and CypB KO mouse tails were transected at the proxi-
mal end, and the histological sections were prepared from the
area 3 mm from the proximal end. The specimens were
immersed for 3 days with 10% formalin and demineralized with
0.5 M EDTA (pH 7.4) for 2 weeks, immersed in 70% ethyl alco-
hol, dehydrated through ascending gradations of ethanol,
embedded in paraffin, and sectioned into 5-m-thick slices.
After hydration, the slices were stained with hematoxylin and
eosin (H&E) and observed under light microscopy (Olympus
BX40 microscope, Olympus, Tokyo, Japan). In addition, to
evaluate the organization and maturation of tendon collagen
matrices, the sections were also stained with 0.1% solution of
Sirius Red in saturated aqueous picric acid (Electron Micros-
copy Sciences, Hatfield, PA) for 60 min, washed with 0.01 N
HCl, dehydrated, and mounted. The fascicles of tail tendon
were observed under polarized light microscopy (BX40 micro-
scope) and photographed as reported previously (29).
Characterization of Collagen Fibrils by Transmission EM—
The specimens were prepared from the same areas as above,
fixed with 2.5% EM grade glutaraldehyde in 0.1 M sodium caco-
dylate buffer, pH 7.4, for 3 days, and demineralized with 0.5 M
EDTA (pH 7.4) for 2 weeks. The samples were then postfixed in
potassium ferrocyanide-reduced osmium for 1 h at room tem-
perature. After rinsing with distilled water, the samples were
dehydrated with a graded series of ethanol concentrations and
embedded in PolyBed-812 epoxy resin (Polysciences, War-
rington, PA). Sections of 70-nm thickness were cut, mounted
on copper Formvar-carbon filmed grids, and stained with 4%
urinary acetate and Reynolds’ lead citrate (30). Cross-sectional
and longitudinal views of the collagen fibrils were observed
using a LEO EM-910 transmission electron microscope oper-
ating at 80 kV (Carl Zeiss SMT, Peabody,MA), and imageswere
taken at 25,000 using a Gatan Orius SC1000 CCD camera
with Digital Micrograph 3.11.0 (Gatan, Inc., Pleasanton, CA).
For each sample, the diameters of 3,000 fibrils were measured
using ImageJ version 1.44p software (National Institutes of
Health, Bethesda, MD).
Collagen Preparation for Biochemical Analysis—Tendons
were prepared from 2-month-old WT, Het, and CypB KO
mouse tails. Both proximal and distal ends of the tail (2 mm
from each end) were cut off, the skin was removed, and tendon
collagen fibers were carefully removed using forceps. All oper-
ations were carried out on ice or at 4 °C. The dissected tendons
were washed several times with cold phosphate-buffered saline
(PBS) and then with cold distilled water by repeated centrifu-
gation at 4,000 g for 30 min and lyophilized.
Collagen Type Analysis—Lyophilized tendons from WT,
Het, and KO mice were heated at 60 °C for 15 min in 50 mM
sodium phosphate buffer (pH 7.2), and the supernatants (gela-
tin) were collected by centrifugation. Collagen types were iden-
tified by LC-MS/MS analysis following trypsin digestion with
searching the acquiredMS/MS spectra against the UniProtKB/
Swiss-Prot database (release 2014_08) using ProteinPilot soft-
ware version 4.0 (AB Sciex, Foster City, CA) as described pre-
viously (31). Types I and III collagen were further quantified by
multiple reaction monitoring (MRM) mode using stable iso-
tope-labeled collagen (SI-collagen) as an internal standard (32).
In brief, SI-collagen was first mixed into the gelatin samples,
and protease digestion by sequencing grade trypsin (Promega,
Madison, WI; 1:100 enzyme/substrate ratio) was performed in
100 mM Tris-HCl, 1 mM CaCl2 (pH 7.6) at 37 °C for 16 h. The
tryptic peptide solutions were subjected to LC-electrospray
ionization-MS using a hybrid triple quadrupole/linear ion trap
3200 QTRAPmass spectrometer (AB Sciex) coupled to an Agi-
lent 1200 seriesHPLC system (Agilent Technologies, Palo Alto,
CA). Marker peptides of type I and III collagens were moni-
tored by MRM mode with reverse-phase separation using an
Ascentis Express C18 HPLC column (5-m particle size,
length  inner diameter 150 mm  2.1 mm; Supelco, Belle-
fonte, PA) (32). Data acquisition and analysis were performed
using Analyst version 1.6.2 (AB Sciex). Concentrations of type I
and type III collagens were estimated by the peak area ratio of
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the marker peptides relative to the isotopically heavy peptides
derived from SI-collagen.
Site-specific Characterization of Post-translationalModifica-
tions of Type I Collagen—The tendon gelatin samples were
digested with trypsin (1:100 enzyme/substrate ratio) in 100mM
Tris-HCl, 1 mM CaCl2 (pH 7.6) at 37 °C for 16 h to analyze the
Lys and Pro post-translational modifications at the specific
molecular sites within the triple helical domain of type I colla-
gen. In parallel, the samples were also digested with recombi-
nant collagenase from Grimontia hollisae (Wako Chemicals,
Osaka, Japan; 1:20 enzyme/substrate ratio) (33) in 100mMTris-
HCl, 5 mM CaCl2 (pH 7.5) at 37 °C for 16 h to analyze Lys
hydroxylation at N- and C-telopeptides of type I collagen. The
peptide solutions digested with trypsin or collagenase were
analyzed by LC-electrospray ionization-MS. Peptideswere sep-
arated on theAscentis Express C18HPLC column at a flow rate
of 500 l/min with a binary gradient as follows: 98% solvent A
(0.1% formic acid) for 2.5 min, linear gradient of 2–50% solvent
B (100% acetonitrile) for 12.5 min, 90% solvent B for 2.5 min,
and 98% solvent A for 2.5 min. Capillary voltage was 4.5 kV,
declustering potential was 30 V, heater gas temperature was
700 °C, curtain gas was 40 p.s.i., nebulizer gas was 50 p.s.i., and
heater gas was 80 p.s.i. Collision energy was 50 V with a
collision energy spread of 15 V for MS/MS analysis. Pep-
tide identification was performed by searching the acquired
MS/MS spectra against the UniProtKB/Swiss-Prot database
with ProteinPilot software version 4.0. Site occupancy of Lys
hydroxylation/glycosylation (Lys, Hyl, galactosyl-Hyl (G-Hyl),
and glucosylgalactosyl-Hyl (GG-Hyl)) and Pro 3-hydroxylation
(3-Hyp)were calculated using the ratio of peak areas of peptides
containing the respective molecular species as reported previ-
ously (27). For Lys hydroxylation at the C-telopeptide domain,
the site occupancy was calculated by a ratio of additionally
combined peak areas ofMS/MS fragments of16Daprecursor
ion derived from those with Lys and Pro hydroxylation,
respectively.
Reduction of Collagen with NaB3H4—Dried tendon samples
(1.0 mg each) were suspended in buffer containing 0.15 M
N-trismethyl-2-aminoethanesulfonic acid and 0.05MTris-HCl,
pH 7.4, and reduced with standardized NaB3H4. The specific
activity of the NaB3H4 was determined by the method de-
scribed previously (34, 35). The reduced samples were washed
with cold distilled water several times by repeated centrifuga-
tion at 4,000 g and lyophilized.
Quantification of GG-Hyl, G-Hyl, and Free Hyl by HPLC—
Reduced collagenwas hydrolyzedwith 6 NHCl and subjected to
amino acid analysis as described previously (36). The level of
total Hyl (GG-Hyl, G-Hyl, and free Hyl) in a collagen molecule
was calculated based on the value of 300 residues of Hyp per
collagen molecule. To determine the level of glycosylated Hyl,
collagen samples were also subjected to base hydrolysis with 2 N
NaOH. GG-Hyl, G-Hyl, and free Hyl in the hydrolysates were
separated with a specific gradient program onHPLC and quan-
tified as residues/collagen molecule as reported (17).
Cross-link Analysis—Reduced collagen was hydrolyzed with
6 N HCl and subjected to cross-link analysis as described previ-
ously (36). Upon reduction, dehydrodihydroxylysinonorleucine
(dehydro-DHLNL)/its ketoamine, dehydrohydroxylysinonor-
leucine (dehydro-HLNL)/its ketoamine, and dehydrohistidino-
hydroxymerodesmosine (dehydro-HHMD) are reduced to sta-
ble secondary amines, DHLNL, HLNL, and HHMD. The
reducible cross-links were analyzed as their reduced forms (i.e.
DHLNL, HLNL, and HHMD). Hereafter, the terms DHLNL,
HLNL, and HHMD will be used for both the unreduced and
reduced forms. The levels of immature reducible (DHLNL,
HLNL, andHHMD) andmature non-reducible cross-links (Pyr
and d-Pyr) were quantified as moles/mole of collagen.
The glycosylated immature reducible cross-links were ana-
lyzed employing base hydrolysis of the reduced samples as
described above (34). By applying the hydrolysates to theHPLC
system, the glycosylated (GG- and G-) and non-glycosylated
cross-links were separated. These forms of cross-links were
quantified as moles/mole of collagen, as reported previously
(18). As for the mature non-reducible cross-link, Pyr, its glyco-
sylated forms were not quantified because it is labile with base
hydrolysis (37).
Interaction of CypB with Lysyl Hydroxylases 1–3 and
FKBP65—The pLVX-Puro2 plasmidwasmodified frompLVX-
Puro (Clontech) plasmid by adding the SbfI and NotI cutting
sites after the XbaI site. The C-terminal 3 FLAG-tagged LH
(LH1, LH2, and LH3) cDNAs were cloned into the XbaI and
NotI sites on pLVX-Puro2 to generate expression plasmids of
LH1-3FLAG, LH2-3FLAG, and LH3-3FLAG. The C-terminal
Myc tagged CypB cDNA was cloned into the XhoI and BamHI
sites on pLVX-Puro to generate CypB-Myc expression plasmid.
The C-terminal HA-HEEL-tagged FKBP65 cDNA was cloned
into the XhoI and BamHI sites on pLVX-Puro to generate
FKBP65-HA expression plasmid. TheHEEL is the ER retention
sequence of FKBP65. Mouse P21 cDNA was cloned in frame
into the HindIII and SalI sites on pCMV-3Tag-7 plasmid (Agi-
lent) to generate the P21-Myc expression plasmid as a negative
control. 293F cells were transfected with different doses (0, 0.1,
and 0.5 g) of Myc-CypB or 0.5 g of Myc-tagged P21 plasmid
and 4 g of FLAG-LHs or HA-tagged FKBP65 plasmids using
Fugene 6 transfection reagent (Promega). At 48 h after trans-
fection, cells were lysed with cell lysis buffer (Cell Signaling
Technology), and the total cell lysateswere preclearedwith PBS
with protein G-agarose. The lysates were incubated with the
Myc antibody (Millipore) on a rotator at 4 °C overnight, and
protein G beads were added to pull down the antibody-protein
complexes. The beads were washed with PBS supplemented
with PMSF five times, and the protein complexes were resolved
from the beads by adding 1 SDS loading buffer and boiling for
5min. The protein samples were subjected toWestern blotting
analysis to detect the presence of proteins with the FLAG
(Sigma), Myc, and HA (Cell Signaling Technology) antibodies.
Statistical Analysis—Statistical analyses were performed
using Jmp version 8.0 software (SAS Institute Inc., Cary, NC).
Statistical differences were determined by Kruskal-Wallis one-
way analysis of variance and means comparison by Student’s t
test. The data are presented as means  S.D., and a p value of
0.05 was considered significant.
Results
Histological Analysis of Collagen Matrix in Tendon—The
effect of CypB deficiency on tendon collagen matrix was first
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examined by light microscopy with H&E and picrosirius red
staining (Fig. 1). H&E-stained cross-sections of tails demon-
strated that tendon collagen bundles in WT and Het mice
were highly organized, and each bundle group contained
10–12 fascicles. In KOmice, however, collagen bundles were
significantly smaller than WT and Het, fragmented, and
poorly organized, and each bundle contained only 5–7 fasci-
cles. When stained with picrosirius red and observed under
polarized light, the collagen matrix of WT and Het mice
showed a relatively uniform orange color indicative of thick
and tightly packed collagen matrix. However, the KO tendon
showed a green and, in some areas, orange/red color, indi-
cating that the collagen fibers are generally thin and are not
packed in an orderly fashion.
Characterization of Collagen Fibrils by Transmission Elec-
tron Microscopy—Tendon collagen fibrils were then analyzed
by transmission electron microscopy. Cross-sectional and lon-
gitudinal views of collagen fibrils and diameter distribution
are shown in Fig. 2. Cross-sectional images demonstrated
that collagen fibril diameters in CypB KO tendon weremark-
edly smaller than WT and Het and irregular in shape. Lon-
gitudinal sections in CypB KO mice also revealed thin fibrils
with varied orientation and often showed branching into
smaller fibrils, as compared with WT and Het. The fibril
diameters were measured from 3,000 randomly selected
fibrils of each animal. In CypB KO mice, the mean fibril
diameters and their ranges were about one-third the size of
fibrils inWT andHetmice (CypB KO, 55 51 nm versusWT
(174  76 nm) and Het (176  90 nm); p  0.001). The
results suggest aberrant lateral growth of fibrils and/or
incorporation of collagen molecules into fibrils in CypB KO
mice. Sections from three animals in each group were exam-
ined, and all showed similar patterns.
Collagen Type—Collagen type was first analyzed by LC-MS/
MS analysis using tryptic digests of gelatinized tendon samples.
Almost all identified peptides were derived from type I collagen
in the tendon samples, and a minute amount of peptide from
type III collagen was identified only in CypB KOmice (data not
shown). Type V collagen was not identified in any of the
samples. Collagen types I and III were further analyzed by
MRM analysis using SI-collagen as an internal standard (32).
FIGURE 1. Histological evaluation of tail tendon. Tail tendons were transected and stained with H&E (top) and picrosirius red (bottom) from wild-type (A),
heterozygous (B), andCypBKO (C)mice. CypBKOmouse tendon contained fewer collagenbundles, each consistingof fewer fascicles that arepoorly organized
andhave anabnormalmorphology. The collagen fibers in theCypBKO tendon showedagreen and, in someareas,orange/red color, whereas thoseofwild-type
and heterozygous mouse tendon show a relatively uniform orange color with picrosirius staining. The arrows indicate the single fascicle in the tendon. VE,
ventral side of tendon; DO, dorsal side of tendon; a, dermis; b, muscle. Bar, 200 m.
FIGURE 2. Ultrastructural analysis of collagen fibrils in tail tendon by
transmissionelectronmicroscopy.A, cross-sectional viewsof the tail tendon
collagen fibrils fromWT, Het, and CypB KOmice. KO tendon fibrils are irregu-
lar in shape and markedly smaller in diameter. Longitudinal sections in KO
showed an axial twist and branch into smaller fibrils. Scale bar, 500 nm. B,
diameter distributionmeasured fromcross-sections. Three thousand fibrils in
each group were measured and plotted.
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Although type III collagen is a very minor collagen type in ten-
don, MRM peaks of marker peptides of type III collagen were
detected in all of the samples by this method. This highly sen-
sitive MS analysis revealed that type III collagen content was
slightly increased in KO tendon (5.3%) compared with WT
(0.4%) and Het (1.9%). Thus, the tendon collagen is predomi-
nantly type I collagen.
Lysine Hydroxylation and Hydroxylysine Glycosylation—
Levels of Lys hydroxylation andmono- (G-) and diglycosylation
(GG-) of Hyl residues of collagen were quantified by HPLC as
reported (17). In CypB KO mouse collagen, the extent of Lys
hydroxylation was moderately but significantly decreased by
22–28% as compared with those from WT and Het mice (p 
0.001) (Table 1A). Because type I collagen represents themajor-
ity of collagen (see above), this indicates that the level of Lys
hydroxylation in the helical domain of type I collagen molecule
is lower in KO mouse tendon. Although the decrease in Lys
hydroxylation was not as striking as in KO skin collagen (27), it
is still distinct from KO bone collagen, in which the extent of
Lys hydroxylation was slightly higher than inWT and Het (27).
The level of Pro hydroxylation in KO collagen was comparable
with those of WT and Het (Table 1A), which is the same as in
bone and skin collagen (27). This suggests that CypB does not
affect 4-hydroxylation of Pro in type I collagen. The results on
Hyl glycosylation revealed that there was a significant decrease
in the level of free Hyl in KO collagen in comparison with those
ofWT andHet (p 0.001), whereas the levels of both GG- and
G-Hyl were comparable among the three groups (Table 1B).
However, when calculated as percentages of GG-Hyl, G-Hyl,
and free Hyl in total Hyl (Table 1C), both GG- (30.2%) and
G-Hyl (3.4%) in KO collagen were slightly but significantly
higher than in WT (23.8% GG-Hyl (p  0.01) and 2.0% G-Hyl
(p 0.01)) andHet (23.5%GG-Hyl (p 0.01) and 2.3%G-Hyl
(p  0.01)). The percentage of free Hyl in KO collagen
(66.4%) was significantly lower compared with those of WT
(74.2%) and Het (74.2%) (p  0.01 in WT, and p  0.01 in
Het) (Table 1C).
Alterations of Collagen Post-translational Modifications at
Specific Molecular Loci—The distributions of Pro 3-hydroxyl-
ation and Lys hydroxylation/glycosylation at specific sites
within the triple helical region of type I collagen were semi-
quantitatively estimated by LC-MS analysis using tryptic
digests of gelatinized tendon samples (Table 2). The values of
WT andHet were almost identical to each other with no statis-
tical difference. In CypB KO tendon, a significant reduction of
Pro 3-hydroxylation at 1(I) Pro-986 was observed (82.1% for
WT, 84.4% for Het, and 17.0% for KO), consistent with our
previous report for bone and skin (27).Only slightly lower 3-hy-
droxylation was observed at 2(I) Pro-707 (76.3% for WT,
82.1% for Het, and 67.5% for KO). The Pro 3-hydroxylation at
1(I) Pro-707 was not affected by the absence of CypB (43.2%
for WT, 47.1% for Het, and 44.9% for KO).
Using the tryptic digests, we then analyzed Lysmodifications
in the triple helical region of type I collagen. These modifica-
tions were found to be in a site-specific manner in the absence
of CypB. The extent of Lys hydroxylation inWT and Het type I
collagenwas also almost identical at all sites analyzed (p 0.1 at
all of the sites). In KO tendon type I collagen, significant un-
derhydroxylation was observed at 1 Lys-87 (66.9% for WT,
68.5% for Het, and 39.1% for KO), 2 Lys-87 (95.6% for WT,
95.1% for Het, and 55.3% for KO), and 2-Lys-174 (70.7% for
WT, 65.6% for Het, and 16.5% for KO). However, Lys hydrox-
TABLE 1
Hydroxylation of lysine and proline, glycosylation of hydroxylysine
(residues/mole of collagen), and percentages of glycosylation in total
hydroxylysine of WT, Het, and CypB KOmouse tendon collagen
Values represent mean S.D. (n	 10) of triplicate analysis of the hydrolysates. A,
Lys hydroxylation was calculated as Hyl/collagen based on the value of 300 residues
of Hyp/collagen. Pro hydroxylation was calculated by Hyp/(Pro  Hyp). B, glyco-
sylation of hydroxylysine was calculated as residues/collagen. free, nonglycosylated
Hyl. C, glycosylation of hydroxylysine (%) represents the relative levels of GG-Hyl,
G-Hyl, and free Hyl (GG-Hyl G-Hyl free-Hyl	 100%).
* Significantly different from both WT and Het (p 0.01).
** Significantly different from both WT and Het (p 0.001).
TABLE 2
Summary of site-specific modification analysis by mass spectrometry
of non-cross-linked, hydroxylated (this table shows Pro hydroxyl-
ation), and glycosylated residues in mice tail tendon type I collagen
Site occupancy
WT Het KO
% % %
1(I) Pro-986 Pro 17.9 1.2 15.6 0.7 83.0 2.7a,b
3-Hyp 82.1 1.2 84.4 0.7 17.0 2.7a,b
1(I) Pro-707 Pro 56.8 3.5 52.9 2.9 55.1 6.1
3-Hyp 43.2 3.5 47.1 2.9 44.9 6.1
2(I) Pro-707 Pro 23.7 4.9 17.9 1.7 32.5 8.8b
3-Hyp 76.3 4.9 82.1 1.7 67.5 8.8b
1(I) Lys-87 Lys 9.0 0.6 3.6 0.3 38.5 5.0a,b
Hyl 66.9 2.4 68.5 2.3 39.1 1.6a,b
G-Hyl 4.9 1.3 6.3 1.0 4.0 0.3b
GG-Hyl 19.2 1.5 21.7 1.4 18.4 3.4
1(I) Lys-174 Lys 58.7 0.8 59.5 3.0 54.1 3.4
Hyl 37.7 0.7 37.2 2.5 38.0 3.0
G-Hyl 2.0 0.1 1.9 0.4 4.9 0.4a,b
GG-Hyl 1.6 0.1 1.5 0.2 2.9 0.4a,b
1(I) Lys-219 Lys 83.5 1.4 82.6 1.1 73.8 3.6a,b
Hyl 16.5 1.4 17.4 1.1 26.2 3.6a,b
1(I) Lys-603 Lys 33.6 0.4 34.5 2.1 32.9 3.2
Hyl 66.4 0.4 65.5 2.1 67.1 3.2
2(I) Lys-87 Lys 4.4 0.4 4.9 0.4 44.7 2.1a,b
Hyl 95.6 0.4 95.1 0.4 55.3 2.1a,b
2(I) Lys-174 Lys 25.5 3.0 31.9 7.9 80.0 1.2a,b
Hyl 70.7 4.3 65.6 6.9 16.5 0.9a,b
G-Hyl 3.4 1.3 2.0 0.6 1.9 0.4
GG-Hyl 0.3 0.1 0.5 0.4 1.5 0.9
2(I) Lys-219 Lys 67.0 0.2 69.7 3.3 55.7 2.5a,b
Hyl 32.2 0.2 29.7 3.2 41.6 2.6a,b
G-Hyl 0.4 0.1 0.3 0.1 1.2 0.2a,b
GG-Hyl 0.4 0.1 0.3 0.0 1.5 0.4a,b
a p 0.05 between WT and KO.
b p 0.05 between Het and KO.
Cyclophilin BModulates Collagen Cross-linking in Tendon
APRIL 29, 2016•VOLUME 291•NUMBER 18 JOURNAL OF BIOLOGICAL CHEMISTRY 9505
ylation at 1 Lys-174, 1 Lys-219, 1 Lys-603, and 2 Lys-219
was unchanged or slightly increased in CypB KO type I colla-
gen. Although the extent of overall glycosylation in tendon type
I collagen is markedly lower than that from skin and bone (32),
the effects of CypB KO on glycosylation patterns were found to
be site-specific. When calculated as percentages of GG-, G-,
and free-Hyl in total Hyl (Table 3), GG-Hyl at 1-87, the major
glycosylation site, was significantly higher in CypBKO collagen
compared with in WT and Het, whereas G-Hyl at this site
showed no difference. Other sites (i.e. 1-174, 2-174, and
2-219)were glycosylated at lower levels comparedwith1-87,
but the relative abundances of bothGG- andG-Hyl inCypBKO
collagen were higher than in WT and Het. Glycosylation at
1-759 that was identified at a very low level in bone (27) was
not detected in any of the tendon samples.
We then analyzed Lys hydroxylation in the telopeptides of
type I collagen after digestion by G. hollisae collagenase (33).
With this treatment, the triple helical region of collagen was
cleaved mostly into the tripeptides (i.e. Gly-X-Y), the majority
of which flowed through the reversed phase column (C18) used
for LC-MS. The N- and C-telopeptides of type I collagen
retained in the column were then eluted and analyzed. We
identified 1(I) N-telopeptide (GYDEKSAGVSVP) and heter-
ogeneous 1(I) C-telopeptide (GPPSGGYDFSFLPQPPQEKS-
QDGGR, -RY, and -RYY), although 2(I) N-telopeptide was
not detected by the LC-MS analysis, probably because of its
involvement in the intra- and/or intermolecular cross-link-
ing. In the case of 1(I) N-telopeptide, because Grimontia
collagenase consistently generated the shorter peptide from
the telopeptide region compared with Clostridium collagen-
ase generating pQMSYGYDEKSAGVSVPGPM (pQ indicates
pyroglutamic acid) (38), Lys hydroxylation can be simply esti-
mated by an increase in the mass of 16 Da in the MS scan (Fig.
3A). Whereas Hyl-containing 1(I) N-telopeptide was not
detected inWT andHet tendon,5% Lys hydroxylation at this
site was observed in CypB KO tendon (Fig. 3, A and C). 1(I)
C-telopeptide generated by Grimontia collagenase was found
to contain Hyp in addition to Hyl by MS/MS analysis (Fig. 4).
Thus, we estimated Lys hydroxylation at the C-telopeptide
using both MS scan and MS/MS fragmentation of the16 Da
FIGURE 3. Lysine hydroxylation in the N- and C-telopeptides of tendon type I collagen. Gelatinized tendon samples were digested by Grimontia
collagenase and subjected to LC-MS analysis. A, monoisotopic extracted ion chromatograms of 1(I) N-telopeptide (GYDEKSAGVSVP, z 	 2; m/z
604.79–605.29 for Lys and m/z 612.79–613.29 for Hyl). B, monoisotopic extracted ion chromatograms of 1(I) C-telopeptide (GPPSGGYDFSFLPQP-
PQEKSQDGGR, z	 3; m/z 883.41–883.74 for Lys and m/z 888.74–889.07 for Hyl and Lys Hyp). Peptide containing Hyl and Hyp (m/z 894.08–894.41,
z 	 3) was under the detection limit. C, Lys hydroxylation at 1(I) N-telopeptide estimated from the peak area ratio of extracted ion chromatograms
shown in A.D, Lys hydroxylation at 1(I) C-telopeptide. The site occupancy was estimated bymultiplicatively combining the peak area ratio of extracted
ion chromatograms shown in B and that of y11–1 ion (Lys Hyp,m/z 1198.58) and y11–2 ion (Hyl,m/z 1214.58) generated by MS/MS fragmentation of the
m/z 888.74 peak (Fig. 4B). Error bars, S.D.
TABLE 3
Glycosylation of hydroxylysine residues estimated bymass spectrom-
etry of non-cross-linked, glycosylated peptides
Hyl G-Hyl GG-Hyl	 100%.
Site occupancy
WT Het KO
% % %
1(I) Lys-87 Hyl 73.5 2.4 71.0 1.9 63.6 2.2a,b
G-Hyl 5.4 1.1 6.5 0.9 6.6 0.5
GG-Hyl 21.1 1.3 22.5 1.2 29.8 2.6a,b
1(I) Lys-174 Hyl 91.3 0.1 91.7 0.6 82.9 1.2a,b
G-Hyl 4.8 0.1 4.6 0.6 10.8 0.7a,b
GG-Hyl 3.9 0.2 3.7 0.2 6.3 0.5a,b
2(I) Lys-174 Hyl 94.9 1.7 96.4 0.8 82.6 2.0a,b
G-Hyl 4.7 1.7 2.9 0.5 9.7 1.6a,b
GG-Hyl 0.4 0.1 0.6 0.4 7.7 3.5
2(I) Lys-219 Hyl 97.4 0.2 98.0 0.1 93.9 1.0a,b
G-Hyl 1.3 0.4 0.9 0.1 2.7 0.4a,b
GG-Hyl 1.3 0.2 1.1 0.0 3.3 0.7a,b
a p 0.05 between WT and KO.
b p 0.05 between Het and KO.
Cyclophilin BModulates Collagen Cross-linking in Tendon
9506 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 18•APRIL 29, 2016
species (Figs. 3B and 4B). It was found that the level of Lys
hydroxylation in the C-telopeptide in KOwas also significantly
increased (12.4%) in comparison with WT (0.9%) and Het
(2.5%) (Fig. 3D). The absence of CypB seemed to have a larger
impact on the Lys hydroxylation in the C-telopeptide. The
higher Lys hydroxylation in the telopeptides is consistent with
the generation of Hylald-derived cross-links in KO tendon col-
lagen (see below).
Collagen Cross-link Analysis—Fig. 5 shows the typical chro-
matographic patterns of collagen cross-links obtained from the
acid hydrolysates of reducedWT,Het, andKO tail tendon sam-
ples. In WT and Het, there were essentially two Lysald-derived
reducible cross-links, a bifunctional cross-link, HLNL, and a
tetravalent cross-link, HHMD, consistent with the cross-link-
ing pattern of mouse tail tendon collagen reported previously
(39). In KO tendon, both of these cross-links were significantly
diminished (i.e.HLNL, 0.697 0.03 inWT, 0.672 0.11 inHet,
and 0.413  0.074 mol/mol of collagen in KO, p  0.001; for
HHMD, 0.894  0.051 in WT, 0.884  0.114 in Het, and
0.492  0.120 mol/mol of collagen in KO, p  0.001, respec-
tively) (Table 4). However, the most striking finding was that
significant amounts of the Hylald-derived reducible cross-link,
DHLNL (0.32 mol/mol collagen), and non-reducible cross-
links, Pyr (0.03 mol/mol collagen), and d-Pyr (0.04 mol/mol
collagen), all of which were absent from WT and Het, were
identified in KO (Figs. 5 and 6). These results strongly indicate
that, in the absence of CypB, the telopeptidyl Lys is significantly
hydroxylated, converted to Hylald, and incorporated into cross-
linking (Table 1). The low ratio of Pyr/d-Pyr in KOmice tendon
indicates underhydroxylation of the helical Lys residues in-
volved in the cross-linking.
Fig. 7 shows the typical chromatographic pattern of the base
hydrolysates obtained from reducedWT, Het, and KO tendon.
The percentages of glycosylated (G- and GG-) and non-glyco-
sylated forms of DHLNL and HLNL are also indicated. The
amount of HHMD cross-link did not change with base hydro-
lysis, indicating that the Hyl residue involved in this cross-link
is not glycosylated. In KO mouse tendon, the relative amounts
FIGURE 4. LC-MS/MS analysis of collagenase-digested 1(I) C-telopeptide. A, MS/MS spectrum of 1(I) C-telopeptide containing Lys (m/z 883.41, z	 3)
from CypB KO tendon. B, MS/MS spectrum of 1(I) C-telopeptide containing Hyl and Lys Hyp (m/z 888.74, z	 3) from CypB KO tendon.
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of glycosylated and non-glycosylated HLNL were comparable
with WT and Het tendon (i.e. 20% glycosylated and 80%
free form in all three groups). Another divalent cross-link,
DHLNL, identified only in KO, was only found to be in the GG
(32%) or free (68%) form. The residue 1-87 (2-87 in rodent
type I collagen) is not glycosylated (17), and themajor glycosyl-
ation site (Table 3) is also the major helical cross-linking site
to form DHLNL (1-16C  1-87) (40). The ratio of GG-
DHLNL to free DHLNL indeed corresponds well to that of
Hyl at 1-87 (Table 3) and is consistent with the increased
Lys hydroxylation in the C-telopeptide (Fig. 3D). The rela-
tive levels of glycosylated and non-glycosylated forms of
DHLNL and HLNL are also shown in Table 4. In KO tendon,
there were significant decreases in the level of free HLNL
and G-HLNL (p 0.001) compared with those fromWT and
Het tendons (Table 4).
Interaction between CypB and Lysyl Hydroxylases 1–3 and
FKBP65—The data above demonstrated that loss of CypB dif-
ferentially affected Lys hydroxylation between the telopeptidyl
and helical domains of the collagen molecule in tendon. This
suggests that CypB may regulate more than one LH function.
Thus, to test whether or not CypB interacts with different LH
isoforms, we coexpressed CypB- or P21-Myc and LH1-3FLAG
in 293F cells. After immunoprecipitating CypB with Myc anti-
body, we detected the associated LHs with FLAG antibody in a
dose-dependent manner, whereas there was a lack of interac-
tion between LHs and P21 (Fig. 8,A and B). This finding clearly
indicated that CypB interacted with not only LH1 but also LH2
and -3. Because loss of CypB increased the telopeptidyl Lys
hydroxylation and, thus, probably LH2 activity, we also inves-
tigated the potential interaction between CypB and the LH2
chaperone, FKBP65. For this, we coexpressed CypB- or P21-
Myc and FKBP65-HA in 293F cells, immunoprecipitated with
Myc antibody, and blotted for FKBP65 with HA antibody (Fig.
8, C and D). The data also showed that the interaction of CypB
with FKBP65 was observed in a dose-dependent manner. No
interaction was detected between P21 and FKBP65. These data
suggest that CypBmay regulate the function of LHs by forming
a complex with LHs and/or the LH2 chaperone, FKBP65.
Discussion
In this study, we demonstrated that the absence of CypB
resulted in a remarkable change in collagen cross-linking
chemistry, defective fibrillogenesis, and tendon tissue degener-
ation. All of the biochemical and histological analyses done in
this study showed that there is no significant phenotypic differ-
ence between WT and Het.
CypBKOmice were generated as amousemodel of recessive
OI (27). CypB is a component of the Pro-3 hydroxylation (P3H)
complex that catalyzes 3-hydroxylation of Pro-986 in the 1
chain and Pro-707 in the 2 chain of type I collagen during
procollagen biosynthesis (27). The deficiency of any compo-
nent of the P3H1 complex leads to recessive OI (24, 41, 42). In
the present study, Pro-986 of the 1 chain is 82–84% 3-hy-
FIGURE 5. Typical chromatographic patterns of collagen cross-links from
theacidhydrolysatesof reduced tail tendonobtained fromWT(top),Het
(middle), and CypB KO (bottom). InWT and Het, cross-links were composed
of HLNL and HHMD. However, in KO, DHLNL, Pyr, and d-Pyr were formed in
addition to HLNL and HHMD.
TABLE 4
Levels of immature reducible cross-links (HLNL, DHLNL, and its glyco-
sylation) andmaturenon-reducible cross-links (Pyr, d-Pyr, andHHMD)
Values represent mean moles/mole of collagen (S.D.) from three independent sam-
ples. A, immature cross-links (DHLNL and its glycosylation); B, immature cross-
links (HLNL and its glycosylation); C, non-reducible cross-links (Pyr, d-Pyr, and
HHMD). *, HHMD was not glycosylated.
a Total DHLNL	 GG-DHLNL G-DHLNL non-glycosylated DHLNL.
b Total HLNL	 GG-HLNL G-HLNL non-glycosylated HLNL.
c Significantly different from both WT and Het.
d ND, not detected.
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droxylated in WT/Het mouse tendon, and it diminished to
17% in KO, indicating that CypB is an important contributor
to this modification but not essential. Distinct from P3H2 KO
mouse tendon (43), 3-hydroxylation of Pro at 1-707 was not
affected in CypB KO tendon collagen. The extent of 3-hydrox-
ylation of Pro at 2-707 in mouse tendon is significantly higher
than in bone and skin collagen (27); however, the decrease in
this modification at this position in CypB KO was moderate. A
recent study has shown that P3H2 expression in tendon is sig-
nificantly higher than P3H1 or P3H3 (44). In addition, the
3-Hyp at Pro-707 of both 1 and 2 chain was significantly
underhydroxylated in tendon type I collagen in P3H2 null mice
(43). Thus, it is likely that P3H2 can hydroxylate this site with-
out requiring CypB in tendon collagen.
The biosynthesis of fibrillar type I collagen requires a number
of specific post-translational modifications, which are criti-
cal for tissue stability (2). Hydroxylation of specific Lys res-
idues catalyzed by LHs is an important modification because
it determines the fate of the cross-linking pathway and pro-
vides the glycosylation sites in type I collagen (2, 17, 18).
Mutations in the LH-encoding genes lead to various connec-
tive diseases, but it has also become clear that defects in
specific ER chaperones/foldases result in aberrant LH func-
tions, suggesting that these ER proteins also control the
functionality of LHs.
By analyzing skin and tendon type I collagen in American
quarter horses with hyperelastosis cutis caused by a CypB mis-
sensemutation, Ishikawa et al.was the first to report that CypB
directly interacts with LH1 and may facilitate its function (28).
An interesting finding in their report is that the extent of sup-
pression in Lys hydroxylation of collagen was significantly dif-
ferent between the two tissues examined. Recently, we have
reported that bone type I collagen of CypB KO mice showed
significantly diminished Lys hydroxylation at the helical cross-
linking sites, suggesting an altered CypB-LH1 interaction (27).
However, except at a limited number of specific sites, overall
Lys hydroxylation in the KO bone collagen was not diminished
by the absence of CypB but instead slightly increased (27). Skin
type I collagen was quite different. In this tissue, Lys hydroxyl-
ation in the whole type I collagenmolecule was severely dimin-
ished, revealing less than one-fifth of that in WT/Het. This
value implies that there is only about one Hyl residue per 
chain in the KO skin type I collagen molecule. We now have
evidence that this extremely low level of Lys hydroxylation in
FIGURE 6.Quantitative cross-link analysis (A) and themajor cross-linking
pathways found (B). A, Lysald-derived (HLNL and HHMD) and Hylald-derived
cross-links (DHLNL, Pyr, and d-Pyr) are shown. Cross-links are expressed as
moles per mole of collagen (mol/mol collagen). In CypB KO tendon colla-
gen, HLNL and HHMD were significantly lower than in WT and Het (p 
0.001). Hylald-derived cross-links were identified only in KO tendon. B, the
major cross-linking pathways in mouse tail tendon collagen. LOX, lysyl
oxidase.
FIGURE7.Typical chromatographicpatternsof collagencross-linksof the
base hydrolysates. Shown are WT (top), Het (middle), and CypB KO (bottom)
mice. The amounts of GG-, G-, and free DHLNL and HLNL are shown in per-
centages (GG-DHLNL DHLNL	 100%, G-HLNL HLNL	 100%). In CypB
KO tendon, the relative amounts of glycosylated (G-) and non-glycosylated
HLNL were comparable with WT and Het tendon. The DHLNL in CypB KO
tendon was found to be the diglycosylated or non-glycosylated form. No
glycosylation was detected for HHMD.
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skin collagen produces abnormal collagen cross-links (data not
shown). Because primary cells from bone and skin of CypB KO
mice abundantly express LH1 at both transcript and protein
levels, this tissue-specific effect on Lys hydroxylation predicts
additional regulatory mechanisms of LH functions in different
tissues. Detailed biochemical analyses of type I collagen in var-
ious tissues are critically important to gain insight into such
mechanisms.
The current study of the KO tendon collagen had a number
of surprises. First, there was severe degeneration of tendon col-
lagen matrices in KO, and the fibrils were markedly small, dis-
organized, and non-uniform. The fibrillar phenotype is similar
to that seen in horse tendon with hyperelastosis cutis (28). Sec-
ond, the effect on Lys hydroxylation in KO tendon collagen was
distinct from both bone and skin collagen. Whereas KO bone
collagen had slightly higher Lys hydroxylation compared with
WT/Het, the extent of Lys hydroxylation in KO tendon colla-
gen was diminished (by22–28%) but not as severe as in skin
(80%). Because type I collagen is the predominant type in KO,
WT, and Het tendon (95%), this demonstrates that tendon
type I collagen in KO represents another distinct molecular
phenotype. Themechanism bywhich Lys hydroxylation is con-
trolled in a tissue-specific manner is still unclear but could pos-
sibly be due to the specific interaction of CypB with other ER
proteins (see below). Third, and most significantly, collagen
cross-linking in KO tendon was quite different from WT/Het.
In mouse tail tendon collagen, the predominant (if not all) col-
lagen cross-links are known to be the Lysald-derived cross-links
forming HLNL (Lysald  Hyl) and HHMD (Lysald  Lysald 
His  Hyl), as seen in WT/Het (39). However, unique to KO
tendon collagen, significant amounts of Hylald-derived cross-
links, such as DHLNL (Hylald  Hyl), Pyr (Hylald  Hylald 
Hyl), and d-Pyr (HylaldHylald Lys) were formed. This indi-
cates that, although overall helical Lys hydroxylation was
diminished, the telopeptidyl Lys hydroxylation was increased
by the absence ofCypB.The total number of aldehydes involved
in cross-linking was not significantly affected, suggesting that
lysyl oxidase activity was not affected by the loss of CypB. Thus,
the main effect of CypB on cross-linking is on the particular
cross-linking pathway utilized rather than on the abundance of
cross-links. Fourth, CypB seems to interact with all LHs and
LH2 chaperone, FKBP65. The interaction between CypB and
LH1 has been reported (28, 45); however, its interaction with
other LHs is not known. The finding that CypB interacts with
all LHs and an LH2 chaperone, FKBP65 (Fig. 8), suggests that
CypB may regulate not only LH1 but also LH2 and -3 activity.
Considering the fact that significant amounts of the Hylald-de-
rived cross-links are formed in KO, whereas they are absent
fromWT/Het, it is tempting to speculate that CypB may nega-
tively control LH2 function as a telopeptidyl LH with LH2
and/or through its chaperone FKBP65. Because LH2 is
expressed ubiquitously in mice, including tendon (46), but the
Hylald-derived cross-links are essentially absent from this tis-
sue, it is possible that, in the normal tendon, LH2 function
could be suppressed by LH2-associated molecules in ER, possi-
bly includingCypB. Thus, in the absence of CypB, LH2 function
could be enhanced, resulting in the formation of the Hylald-
derived cross-links. Further studies are necessary to validate
this hypothesis. At all glycosylation sites analyzed, the relative
abundance of glycosylated Hyl per total Hyl was generally
FIGURE 8. CypB binds to LHs and FKBP65. Binding assay in a cell culture system. 293F cells were transiently co-transfected with CypB or P21-Myc and
LHs-FLAG or FKBP65-HA plasmids and subjected to co-immunoprecipitation (IP). After 48 h, the cells were lysed, and CypB or p21 protein complexes were
immunoprecipitated from the lysates with the anti-Myc antibody or normal mouse IgG as a negative control. The pulldown of CypB or P21 was confirmed by
Westernblotting analysiswith anti-Myc antibody, and thepull-downof LHs or FKBP65proteinswas confirmedwith an anti-FLAGorHAantibody.A, interaction
between CypB or P21 and LH1, -2, and -3. B, interaction between CypB and LHs by increasing concentrations of CypB. C, interaction between CypB or P21 and
FKBP65. D, interaction between CypB and FKBP65 by increasing concentrations of CypB.
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higher in KO than inWT/Het (Table 3). It is of interest to note
that the relative abundance of GG-Hyl in total Hyl at the major
glycosylation site, 1-87, was significantly higher in KO than
WT/Het, although that of G-Hyl was unaffected. Because CypB
appears to interact with LH3 (Fig. 8), CypB may also regulate
LH3 function as a glucosyltransferase (17) at specific sites. The
delay in collagen folding from the absence of CypB (27) could
also be a contributing factor to such overglucosylation. Al-
though we confirmed the interaction between CypB and LHs/
FKBP65 by co-immunoprecipitation using a whole cell extract,
this does not prove the direct protein-protein interaction. A
comprehensive characterization of the interaction, such as
direct binding, binding kinetics, and determination of the bind-
ing sites,may provide further insights into themolecularmech-
anisms and biological significance of the CypB-controlled col-
lagen post-translational modification.
In CypB KO mice, whereas the extent of decrease in Lys
hydroxylation in the helical domain varies depending on the
tissues (i.e. bone, skin, and tendon), a significant decrease of
this modification at the helical cross-linking sites (i.e. 1/2-
87) appears to be a common molecular phenotype in all of
these three tissues. The reason for this specificity is not clear at
present. Considering the fact that these are the major glycosyl-
ation sites of type I collagen (17, 40), Lys hydroxylation at these
sites may occur in the context of sequential modifications
involving multiple enzymes, i.e. LH1, glycosyltransferases such
as a glycosyltransferase 25 domain 1 (GLT25D1) and LH3, a
complex process in which CypB may be required.
One unresolved question is whether the phenotypes seen in
CypB KO tendon (i.e. aberrant organization, degenerative col-
lagen bundles, small/non-uniform fibrils) are due to the dimin-
ished P3Hor altered Lysmodifications, including cross-linking.
A hypothesis on the role of P3H proposed byWeis et al. (47) is
that it helps to fine tune the supramolecular assembly of colla-
gen fibrils by providing inter-triple helical hydrogen bonding.
Thus, the lack of 3-Hyp may impair fibrillogenesis. A study on
tendon fromhorses with hyperelastosis cutismay provide addi-
tional insight. In this model, the level of P3H was not signifi-
cantly affected, yet the aberrant fibrillar morphology is remark-
ably similar to that seen in CypB KO tendon. This suggests that
the fibrillar phenotype is caused by defects other than P3H. In
addition, we also reported that, when LH2 is overexpressed, the
resultant collagen fibrils become small in diameter (48). These
results suggest that the phenotype seen in CypB KO tendon
might be due mainly to altered Lys modifications rather than
diminished P3H. Another possibility is that the altered post-
translationalmodifications of collagen inCypBKOmay change
its interaction with collagen-associated small leucine-rich pro-
teoglycans, such as decorin, biglycan, and fibromodulin, result-
ing in defective fibrils (49, 50).
In conclusion, this study demonstrated that CypBmodulates
collagen cross-linking chemistry by differentially affecting Lys
hydroxylation in the helical and telopeptidyl domains of tendon
type I collagen, possibly via its specific interaction with LH iso-
forms and associated molecules, FKBP65. The deficiency of
CypB causes aberrant cross-linking and defective tendon tissue
formation. These results underscore the critical role of this ER
protein in collagen stability and assembly.
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